Does Rallies show 13F holders for XLV?

Yes. Rallies tracks hedge fund and 13F ownership data for XLV, including fund names, share counts, latest tracked quarter, and position changes when available.

Is XLV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XLV. It does not provide personalized investment advice.

XLV (Health Care Select) Stock Analysis - Hedge Fund Holdings

Health Care Select (XLV) is a publicly traded Financial Services sector company. As of May 20, 2026, XLV trades at $146.95 with a market cap of $0 and a P/E ratio of 0.00. XLV moved -0.14% today. Year to date, XLV is -5.27%; over the trailing twelve months it is +9.64%. Its 52-week range spans $127.35 to $160.59. Rallies surfaces XLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns XLV stock?

Hedge funds tracked by Rallies that own XLV include Rokos Capital, Pinebridge Investments, and Bluecrest Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Health Care Select.

XLV Key Metrics

Key financial metrics for XLV
Metric	Value
Price	$146.95
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.59%
52-Week High	$160.59
52-Week Low	$127.35
Volume	10.30M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding XLV

Rokos Capital holds 1.04M shares of XLV, changed -37.49% as of Mar 31, 2026.
Pinebridge Investments holds 35.01K shares of XLV, changed +0.00% as of Sep 30, 2024.
Bluecrest Capital holds 8.64K shares of XLV, changed +0.00% as of Sep 30, 2025.

Latest XLV News

XLV holds flat as UNH/CVS earnings read-through offsets big-pharma drift — May 7, 2026
XLV flat as rates and mega-cap pharma/insurer cross-currents offset each other — May 6, 2026
XLV Flat as Healthcare Megacaps Offset; FDA GLP-1 Compounding Shift Stays in Focus — May 5, 2026
XLV holds near $145 as healthcare digests rates and GLP-1 momentum — May 4, 2026
California’s 5% Billionaire Wealth Tax Proposal Aims to Fund $100B Healthcare Boost — May 2, 2026

XLV Analyst Consensus

XLV analyst coverage data. Average price target: $0.00.

Common questions about XLV

Who owns XLV stock?: Hedge funds tracked by Rallies that own XLV include Rokos Capital, Pinebridge Investments, and Bluecrest Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Health Care Select.
Does Rallies show 13F holders for XLV?: Yes. Rallies tracks hedge fund and 13F ownership data for XLV, including fund names, share counts, latest tracked quarter, and position changes when available.
Is XLV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XLV. It does not provide personalized investment advice.